AAAAAA

   
Results: 1-25 | 26-28
Results: 1-25/28
Application of HIV-1 genotypic-resistance testing prevents the evolution of further resistance mutations in heavily pretreated patients
Authors: Zollner, B Feucht, HH Weitner, L Adam, A Schroter, M Schafer, P Laufs, R
Citation: B. Zollner et al., Application of HIV-1 genotypic-resistance testing prevents the evolution of further resistance mutations in heavily pretreated patients, J CLIN VIRO, 21(1), 2001, pp. 37-45
Primary genotypic resistance of HIV-1 to the fusion inhibitor T-20 in long-term infected patients
Authors: Zollner, B Feucht, HH Schroter, M Schafer, P Plettenberg, A Stoehr, A Laufs, R
Citation: B. Zollner et al., Primary genotypic resistance of HIV-1 to the fusion inhibitor T-20 in long-term infected patients, AIDS, 15(7), 2001, pp. 935-936
Correlation of hepatitis B virus load with loss of e antigen and emerging drug-resistant variants during lamivudine therapy
Authors: Zollner, B Schafer, P Feucht, HH Schroter, M Petersen, J Laufs, R
Citation: B. Zollner et al., Correlation of hepatitis B virus load with loss of e antigen and emerging drug-resistant variants during lamivudine therapy, J MED VIROL, 65(4), 2001, pp. 659-663
Strategies for reliable diagnosis of hepatitis C infection: The need for aserological confirmatory assay
Authors: Schroter, M Schafer, P Zollner, B Polywka, S Laufs, R Feucht, HH
Citation: M. Schroter et al., Strategies for reliable diagnosis of hepatitis C infection: The need for aserological confirmatory assay, J MED VIROL, 64(3), 2001, pp. 320-324
20-fold increase in risk of lamivudine resistance in hepatitis B virus subtype adw
Authors: Zollner, B Petersen, J Schroter, M Laufs, R Schoder, V Feucht, HH
Citation: B. Zollner et al., 20-fold increase in risk of lamivudine resistance in hepatitis B virus subtype adw, LANCET, 357(9260), 2001, pp. 934-935
Relevance of reactivity in commercially available hepatitis C virus antibody assays
Authors: Polywka, S Schroter, M Feucht, HH Zollner, B Laufs, R
Citation: S. Polywka et al., Relevance of reactivity in commercially available hepatitis C virus antibody assays, J CLIN MICR, 39(4), 2001, pp. 1665-1668
Quantitative detection of hepatitis C virus RNA by light cycler PCR and comparison with two different PCR assays
Authors: Schroter, M Zollner, B Schafer, P Laufs, R Feucht, HH
Citation: M. Schroter et al., Quantitative detection of hepatitis C virus RNA by light cycler PCR and comparison with two different PCR assays, J CLIN MICR, 39(2), 2001, pp. 765-768
Prevalence of a novel DNA virus (TTV) among patients on maintenance hemodialysis
Authors: Schroter, M Feucht, HH Zollner, B Schafer, P Laufs, R
Citation: M. Schroter et al., Prevalence of a novel DNA virus (TTV) among patients on maintenance hemodialysis, NEPHRON, 87(2), 2001, pp. 139-142
Biofilm formation by Staphylococcus epidermidis depends on functional RsbU, an activator of the sigB operon: Differential activation mechanisms due to ethanol and salt stress
Authors: Knobloch, JKM Bartscht, K Sabottke, A Rohde, H Feucht, HH Mack, D
Citation: Jkm. Knobloch et al., Biofilm formation by Staphylococcus epidermidis depends on functional RsbU, an activator of the sigB operon: Differential activation mechanisms due to ethanol and salt stress, J BACT, 183(8), 2001, pp. 2624-2633
Nosocomial outbreak of vancomycin-resistant Enterococcus faecium at a German University Pediatric Hospital
Authors: Elsner, HA Sobottka, I Feucht, HH Harps, E Haun, C Mack, D Ganschow, R Laufs, R Kaulfers, PM
Citation: Ha. Elsner et al., Nosocomial outbreak of vancomycin-resistant Enterococcus faecium at a German University Pediatric Hospital, INT J HYG E, 203(2), 2000, pp. 147-152
In vivo dynamics and pathogenicity of wild-type and resistant Hepatitis B virus during long-term lamivudine monotherapy - a clinical note
Authors: Zollner, B Stoehr, A Plettenberg, A Feucht, HH Schroter, M Schafer, P Laufs, R
Citation: B. Zollner et al., In vivo dynamics and pathogenicity of wild-type and resistant Hepatitis B virus during long-term lamivudine monotherapy - a clinical note, J CLIN VIRO, 17(3), 2000, pp. 183-188
Association of qacE and qacE Delta 1 with multiple resistance to antibiotics and antiseptics in clinical isolates of Gram-negative bacteria
Authors: Kucken, D Feucht, HH Kaulfers, PM
Citation: D. Kucken et al., Association of qacE and qacE Delta 1 with multiple resistance to antibiotics and antiseptics in clinical isolates of Gram-negative bacteria, FEMS MICROB, 183(1), 2000, pp. 95-98
Rapid clearance of human immunodeficiency virus type 1 from ventricular cerebrospinal fluid during antiretroviral treatment
Authors: Eggers, C Stuerenburg, HJ Schafft, T Zollner, B Feucht, HH Stellbrink, HJ van Lunzen, J
Citation: C. Eggers et al., Rapid clearance of human immunodeficiency virus type 1 from ventricular cerebrospinal fluid during antiretroviral treatment, ANN NEUROL, 47(6), 2000, pp. 816-819
Detection of TT virus DNA and GB virus type C/hepatitis G virus RNA in serum and breast milk: Determination of mother-to-child transmission
Authors: Schroter, M Polywka, S Zollner, B Schafer, P Laufs, R Feucht, HH
Citation: M. Schroter et al., Detection of TT virus DNA and GB virus type C/hepatitis G virus RNA in serum and breast milk: Determination of mother-to-child transmission, J CLIN MICR, 38(2), 2000, pp. 745-747
Identification of three essential regulatory gene loci governing expression of Staphylococcus epidermidis polysaccharide intercellular adhesin and biofilm formation
Authors: Mack, D Rohde, H Dobinsky, S Riedewald, J Nedelmann, M Knobloch, JKM Elsner, HA Feucht, HH
Citation: D. Mack et al., Identification of three essential regulatory gene loci governing expression of Staphylococcus epidermidis polysaccharide intercellular adhesin and biofilm formation, INFEC IMMUN, 68(7), 2000, pp. 3799-3807
In vitro susceptibilities of enterococcal blood culture isolates from the Hamburg area to ten antibiotics
Authors: Elsner, HA Sobottka, I Feucht, HH Claussen, M Kaulfers, PM Laufs, R Mack, D
Citation: Ha. Elsner et al., In vitro susceptibilities of enterococcal blood culture isolates from the Hamburg area to ten antibiotics, CHEMOTHERA, 46(2), 2000, pp. 104-110
High rate of chronicity in HCV infection determined by antibody confirmatory assay and PCR in 4110 patients during long-term follow-up
Authors: Feucht, HH Zollner, B Schroter, M Polywka, S Buggisch, P Nolte, H Laufs, R
Citation: Hh. Feucht et al., High rate of chronicity in HCV infection determined by antibody confirmatory assay and PCR in 4110 patients during long-term follow-up, J CLIN VIRO, 13(1-2), 1999, pp. 43-51
Prevalence of TTV viremia among healthy subjects and individuals at risk for parenterally transmitted diseases in Germany
Authors: Schroter, M Feucht, HH Zollner, B Knodler, B Schafer, P Fischer, L Laufs, R
Citation: M. Schroter et al., Prevalence of TTV viremia among healthy subjects and individuals at risk for parenterally transmitted diseases in Germany, HEPATOL RES, 13(3), 1999, pp. 205-211
Low risk of vertical transmission of hepatitis C virus by breast milk
Authors: Polywka, S Schroter, M Feucht, HH Zollner, B Laufs, R
Citation: S. Polywka et al., Low risk of vertical transmission of hepatitis C virus by breast milk, CLIN INF D, 29(5), 1999, pp. 1327-1329
GB virus C hepatitis G virus infection in hemodialysis patients: Determination of seroprevalence by a four-antigen recombinant immunoblot assay
Authors: Schroter, M Feucht, HH Schafer, P Zollner, B Laufs, R
Citation: M. Schroter et al., GB virus C hepatitis G virus infection in hemodialysis patients: Determination of seroprevalence by a four-antigen recombinant immunoblot assay, J MED VIROL, 57(3), 1999, pp. 230-234
Drug-resistant genotyping in HIV-1 therapy
Authors: Zollner, B Feucht, HH Weitner, L Adam, A Laufs, R
Citation: B. Zollner et al., Drug-resistant genotyping in HIV-1 therapy, LANCET, 354(9184), 1999, pp. 1120-1121
Serological determination of hepatitis C virus subtypes 1a, 1b, 2a, 2b, 3a, and 4a by a recombinant immunoblot assay
Authors: Schroter, M Feucht, HH Schafer, P Zollner, B Laufs, R
Citation: M. Schroter et al., Serological determination of hepatitis C virus subtypes 1a, 1b, 2a, 2b, 3a, and 4a by a recombinant immunoblot assay, J CLIN MICR, 37(8), 1999, pp. 2576-2580
Age-dependent acquisition of hepatitis G virus GB virus C in a nonrisk population: Detection of the virus by antibodies
Authors: Feucht, HH Schroter, M Zollner, B Polywka, S Laufs, R
Citation: Hh. Feucht et al., Age-dependent acquisition of hepatitis G virus GB virus C in a nonrisk population: Detection of the virus by antibodies, J CLIN MICR, 37(5), 1999, pp. 1294-1297
Definition of false-positive reactions in screening for hepatitis C virus antibodies
Authors: Schroter, M Feucht, HH Schafer, P Zollner, B Polywka, S Laufs, R
Citation: M. Schroter et al., Definition of false-positive reactions in screening for hepatitis C virus antibodies, J CLIN MICR, 37(1), 1999, pp. 233-234
Treatment of severe recurrent hepatitis C after liver transplantation withribavirin plus interferon alpha
Authors: Fischer, L Sterneck, M Valentin-Gamazo, C Feucht, HH Malago, M Broelsch, CE
Citation: L. Fischer et al., Treatment of severe recurrent hepatitis C after liver transplantation withribavirin plus interferon alpha, TRANSPLAN P, 31(1-2), 1999, pp. 494-495
Risultati: 1-25 | 26-28